GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Price-to-Owner-Earnings

Evoq Remedies (BOM:543500) Price-to-Owner-Earnings : 2.26 (As of Sep. 26, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Price-to-Owner-Earnings?

As of today (2024-09-26), Evoq Remedies's share price is ₹8.80. Evoq Remedies's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹3.90. It's Price-to-Owner-Earnings for today is 2.26.


The historical rank and industry rank for Evoq Remedies's Price-to-Owner-Earnings or its related term are showing as below:

BOM:543500' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.27   Med: 2.45   Max: 3.05
Current: 2.27

During the past 6 years, the highest Price-to-Owner-Earnings of Evoq Remedies was 3.05. The lowest was 2.27. And the median was 2.45.


BOM:543500's Price-to-Owner-Earnings is ranked better than
93.88% of 49 companies
in the Medical Distribution industry
Industry Median: 13.4 vs BOM:543500: 2.27

As of today (2024-09-26), Evoq Remedies's share price is ₹8.80. Evoq Remedies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.34. Therefore, Evoq Remedies's PE Ratio (TTM) for today is 26.19.

As of today (2024-09-26), Evoq Remedies's share price is ₹8.80. Evoq Remedies's EPS without NRI for the trailing twelve months (TTM) ended in was ₹0.34. Therefore, Evoq Remedies's PE Ratio without NRI for today is 26.19.

During the past 6 years, Evoq Remedies's highest PE Ratio without NRI was 192.10. The lowest was 7.29. And the median was 19.57.


Evoq Remedies Price-to-Owner-Earnings Historical Data

The historical data trend for Evoq Remedies's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Price-to-Owner-Earnings Chart

Evoq Remedies Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - 2.22

Evoq Remedies Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only - - - - 2.22

Competitive Comparison of Evoq Remedies's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Evoq Remedies's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evoq Remedies's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Evoq Remedies's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Evoq Remedies's Price-to-Owner-Earnings falls into.



Evoq Remedies Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Evoq Remedies's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=8.80/3.90
=2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evoq Remedies  (BOM:543500) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Evoq Remedies Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Evoq Remedies Business Description

Traded in Other Exchanges
N/A
Address
Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies Headlines

No Headlines